US Stock MarketDetailed Quotes

LVTX LAVA Therapeutics

Watchlist
  • 2.390
  • -0.250-9.47%
Close May 28 16:00 ET
  • 2.450
  • +0.060+2.51%
Post 17:04 ET
62.84MMarket Cap-2254P/E (TTM)

LAVA Therapeutics Key Stats

LAVA Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

6.99M

+471.24%
EPS(YoY)

-0.02

+96.23%

Strong Buy

Mar 21, 2024

LAVA Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q16.440M / 3.238M--
--2023/Q4325.040K / 5.796M--
--2023/Q348.790K / 0.000--
--2023/Q24.720M / 576.000K--
--2023/Q11.136M / 0.000--
--2022/Q42.434M / 233.000K--
--2022/Q314.670M / 10.566M--
--2022/Q2467.720K / 318.670K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q16.440M / 3.238M--
--2023/Q4325.040K / 5.796M--
--2023/Q348.790K / 0.000--
--2023/Q24.720M / 576.000K--
--2023/Q11.136M / 0.000--
--2022/Q42.434M / 233.000K--
--2022/Q314.670M / 10.566M--
--2022/Q2467.720K / 318.670K--

Unlock Free Earnings Estimates

LAVA Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Mar 21, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg